FCAM
DGX icon

F&C Asset Management’s Quest Diagnostics DGX Stock Holding History

F&C Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$622K Buy
10,734
+198
+2% +$10.6K 0.01% 622
2013
Q4 		$564K Buy
10,536
+1,261
+14% +$74.8K 0.01% 635
2013
Q3 		$573K Sell
9,275
-1,094
-11% -$65.5K 0.01% 632
2013
Q2 		$629K Buy
+10,369
New +$618K 0.01% 621

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

F&C Asset Management's DGX Position: Q1 2014 in Review

F&C Asset Management increased its Quest Diagnostics (DGX) stake by 1.9% in Q1 2014, buying an estimated $10.6K and bringing the position to 10,734 shares worth $622K. The position accounts for 0.01% of the portfolio, ranked #622.

F&C Asset Management first reported a position in DGX in Q2 2013 and has held it in 4 quarters since. The position peaked at $629K in Q2 2013. 491 funds tracked by Wall St. Rank hold DGX as of Q1 2014.

  • F&C Asset Management held 10,734 shares of Quest Diagnostics worth $622K as of Q1 2014.
  • F&C Asset Management bought 198 Quest Diagnostics shares in Q1 2014, an estimated $10.6K.
  • Quest Diagnostics made up 0.01% of F&C Asset Management's portfolio in Q1 2014, its #622 holding.
  • F&C Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 4 quarters since.
  • F&C Asset Management's Quest Diagnostics position peaked at $629K in Q2 2013.
  • 491 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.